Surface Oncology
Why Robinhood?
You can watch SURF and buy or sell other stocks, ETFs, and their options commission-free!About SURF
Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company, which engages in the provision of biological pathways critical to the immunosuppressive tumor microenvironment for the development of next-generation cancer therapies. The firm’s pipeline includes wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114).
SURF Key Statistics
Stock Snapshot
With a market cap of 65.08M, Surface Oncology(SURF) trades at $1.07. The stock has a price-to-earnings ratio of -0.70.
Surface Oncology(SURF) stock opened on 2026-03-10 at —. The price climbed to — and dipped to —.
Surface Oncology(SURF) shares are trading with a volume of 0, against a daily average of 292.98K.
During the past year, Surface Oncology(SURF) stock moved between $0.56 at its lowest and $1.43 at its peak.
During the past year, Surface Oncology(SURF) stock moved between $0.56 at its lowest and $1.43 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.